$1,318.00
This Market Spotlight report covers the Sjögren’s syndrome market, comprising key pipeline and marketed drugs, clinical trials, upcoming events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals.
This Market Spotlight report covers the Sjögren’s Syndrome market, comprising key marketed and pipeline drugs, key upcoming events, clinical trials, probability of success, and a 10-year disease prevalence forecast.
CONTENTS
5 OVERVIEW
6 KEY TAKEAWAYS
7 DISEASE BACKGROUND
8 TREATMENT
8 Dry eyes
8 Dry mouth
8 Other glandular manifestations
9 Extraglandular manifestations
10 EPIDEMIOLOGY
14 MARKETED DRUGS
16 PIPELINE DRUGS
21 KEY UPCOMING EVENTS
22 PROBABILITY OF SUCCESS
23 CLINICAL TRIAL LANDSCAPE
24 Sponsors by status
25 Sponsors by phase
27 BIBLIOGRAPHY
28 APPENDIX
LIST OF FIGURES
12 Figure 1: Trends in prevalent cases of primary Sjögren’s syndrome, 2019–28
16 Figure 2: Overview of pipeline drugs for Sjögren’s syndrome in the US
16 Figure 3: Pipeline drugs for Sjögren’s syndrome, by company
17 Figure 4: Pipeline drugs for Sjögren’s syndrome, by drug type
17 Figure 5: Pipeline drugs for Sjögren’s syndrome, by classification
21 Figure 6: Key upcoming events in Sjögren’s syndrome
22 Figure 7: Probability of success in the arthritis pipeline
23 Figure 8: Clinical trials in Sjögren’s syndrome
23 Figure 9: Top 10 drugs for clinical trials in Sjögren’s syndrome
24 Figure 10: Top 10 companies for clinical trials in Sjögren’s syndrome
24 Figure 11: Trial locations in Sjögren’s syndrome
25 Figure 12: Sjögren’s syndrome trials status
26 Figure 13: Sjögren’s syndrome trials sponsors, by phase
LIST OF TABLES
11 Table 1: Prevalent cases of primary Sjögren’s syndrome, 2019–28
13 Table 2: Prevalent cases of primary Sjögren’s syndrome, by gender, 2019
15 Table 3: Marketed drugs for Sjögren’s syndrome
18 Table 4: Pipeline drugs for Sjögren’s syndrome in the US
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!